TDP-43

N/A

Report date: 2025/01/26 17:20:24

Base Information

Drug NameTDP-43
Drug Alias NameTDP-43 targeting antibodies (Prothena)TDP-43 targeting antibodies (Prothena/Bristol-Myers Squibb)TDP-43
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTAR DNA binding protein 43 inhibitors
TargetsTAR DNA binding protein 43
Therapy Area/IndicationsNerve DegenerationAmyotrophic Lateral SclerosisFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProthena Corp Plc
China Registration ClassN/A

Develop Information

Active CompaniesProthena Corp PlcBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsNerve DegenerationAmyotrophic Lateral SclerosisFrontotemporal Dementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A